Copyright Reports & Markets. All rights reserved.

Global Rotavirus Infections Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Rotavirus Infections Drug Market Overview

      • 1.1 Product Overview and Scope of Rotavirus Infections Drug
      • 1.2 Rotavirus Infections Drug Segment by Type
        • 1.2.1 Global Rotavirus Infections Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 RV-3BB
        • 1.2.3 RV-625
        • 1.2.4 UMN-2001
        • 1.2.5 Rotavac-5C
        • 1.2.6 Others
      • 1.3 Rotavirus Infections Drug Segment by Application
        • 1.3.1 Rotavirus Infections Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.3 Global Rotavirus Infections Drug Market by Region
        • 1.3.1 Global Rotavirus Infections Drug Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Rotavirus Infections Drug Market Size
        • 1.4.1 Global Rotavirus Infections Drug Revenue (2014-2025)
        • 1.4.2 Global Rotavirus Infections Drug Production (2014-2025)

      2 Global Rotavirus Infections Drug Market Competition by Manufacturers

      • 2.1 Global Rotavirus Infections Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Rotavirus Infections Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Rotavirus Infections Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Rotavirus Infections Drug Production Sites, Area Served, Product Types
      • 2.5 Rotavirus Infections Drug Market Competitive Situation and Trends
        • 2.5.1 Rotavirus Infections Drug Market Concentration Rate
        • 2.5.2 Rotavirus Infections Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Rotavirus Infections Drug Production Market Share by Regions

      • 3.1 Global Rotavirus Infections Drug Production Market Share by Regions
      • 3.2 Global Rotavirus Infections Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Rotavirus Infections Drug Production
        • 3.4.1 North America Rotavirus Infections Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Rotavirus Infections Drug Production
        • 3.5.1 Europe Rotavirus Infections Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Rotavirus Infections Drug Production (2014-2019)
        • 3.6.1 China Rotavirus Infections Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Rotavirus Infections Drug Production (2014-2019)
        • 3.7.1 Japan Rotavirus Infections Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Rotavirus Infections Drug Consumption by Regions

      • 4.1 Global Rotavirus Infections Drug Consumption by Regions
      • 4.2 North America Rotavirus Infections Drug Consumption (2014-2019)
      • 4.3 Europe Rotavirus Infections Drug Consumption (2014-2019)
      • 4.4 China Rotavirus Infections Drug Consumption (2014-2019)
      • 4.5 Japan Rotavirus Infections Drug Consumption (2014-2019)

      5 Global Rotavirus Infections Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Rotavirus Infections Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Rotavirus Infections Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Rotavirus Infections Drug Price by Type (2014-2019)
      • 5.4 Global Rotavirus Infections Drug Production Growth by Type (2014-2019)

      6 Global Rotavirus Infections Drug Market Analysis by Applications

      • 6.1 Global Rotavirus Infections Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Rotavirus Infections Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Rotavirus Infections Drug Business

      • 7.1 Beijing Minhai Biotechnology Co Ltd
        • 7.1.1 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Production Sites and Area Served
        • 7.1.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Bharat Biotech International Ltd
        • 7.2.1 Bharat Biotech International Ltd Rotavirus Infections Drug Production Sites and Area Served
        • 7.2.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Biological E Ltd
        • 7.3.1 Biological E Ltd Rotavirus Infections Drug Production Sites and Area Served
        • 7.3.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.3.3 Biological E Ltd Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Curevac AG
        • 7.4.1 Curevac AG Rotavirus Infections Drug Production Sites and Area Served
        • 7.4.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.4.3 Curevac AG Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Medicago Inc
        • 7.5.1 Medicago Inc Rotavirus Infections Drug Production Sites and Area Served
        • 7.5.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.5.3 Medicago Inc Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Nanotherapeutics Inc
        • 7.6.1 Nanotherapeutics Inc Rotavirus Infections Drug Production Sites and Area Served
        • 7.6.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Serum Institute of India Ltd
        • 7.7.1 Serum Institute of India Ltd Rotavirus Infections Drug Production Sites and Area Served
        • 7.7.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 UMN Pharma Inc
        • 7.8.1 UMN Pharma Inc Rotavirus Infections Drug Production Sites and Area Served
        • 7.8.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.8.3 UMN Pharma Inc Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Wuhan Institute of Biological Products Co Ltd
        • 7.9.1 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Production Sites and Area Served
        • 7.9.2 Rotavirus Infections Drug Product Introduction, Application and Specification
        • 7.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Rotavirus Infections Drug Manufacturing Cost Analysis

      • 8.1 Rotavirus Infections Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Rotavirus Infections Drug
      • 8.4 Rotavirus Infections Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Rotavirus Infections Drug Distributors List
      • 9.3 Rotavirus Infections Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Rotavirus Infections Drug Market Forecast

      • 11.1 Global Rotavirus Infections Drug Production, Revenue Forecast
        • 11.1.1 Global Rotavirus Infections Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Rotavirus Infections Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Rotavirus Infections Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Rotavirus Infections Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Rotavirus Infections Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Rotavirus Infections Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Rotavirus Infections Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Rotavirus Infections Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Rotavirus Infections Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Rotavirus Infections Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Rotavirus Infections Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Rotavirus Infections Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Rotavirus Infections Drug Consumption Forecast (2019-2025)
      • 11.4 Global Rotavirus Infections Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Rotavirus Infections Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Rotavirus Infections Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Rotavirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Beijing Minhai Biotechnology Co Ltd
        Bharat Biotech International Ltd
        Biological E Ltd
        Curevac AG
        Medicago Inc
        Nanotherapeutics Inc
        Serum Institute of India Ltd
        UMN Pharma Inc
        Wuhan Institute of Biological Products Co Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        RV-3BB
        RV-625
        UMN-2001
        Rotavac-5C
        Others

        Segment by Application
        Clinic
        Hospital
        Others

        Buy now